Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03335813 · ClinicalTrials.gov registry record · NA
Endoesophageal Brachytherapy for Patients With Esophageal Cancer
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03335813 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 7 participants.
The verdict
NCT03335813, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Depending upon the cancer stage, esophageal cancer can be treated with surgery, chemotherapy, radiation therapy, or a combination of these modalities. Sometimes in addition to external radiation therapy or instead of external radiation therapy, select patients with esophageal cancer may benefit from localized radiation to the tumor, called esophageal brachytherapy. There are many different radiation techniques and delivery approaches for this type of specialized radiation therapy, and the purpose of this document is to provide a written summary of an innovative delivery method.
Interventions
- DEVICE Endoesophageal Brachytherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-03-06 |
| Est. Completion | 2020-12-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03335813
The ClinicalTrials.gov registry entry for NCT03335813 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Endoesophageal Brachytherapy is the first listed.
NCT03335813 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03335813 about?
NCT03335813 is a clinical study titled "Endoesophageal Brachytherapy for Patients With Esophageal Cancer". Depending upon the cancer stage, esophageal cancer can be treated with surgery, chemotherapy, radiation therapy, or a combination of these modalities. Sometimes in addition to external radiation therapy or instead of external radiation therapy, select patients with esophageal cancer may benefit from...
What is the current status of trial NCT03335813?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2018-03-06. Estimated completion is 2020-12-08.
What interventions are being tested in trial NCT03335813?
The interventions under investigation include: Endoesophageal Brachytherapy (DEVICE).
Who is sponsoring clinical trial NCT03335813?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.